Recommended Treatments for Nausea
For acute nausea and vomiting without alarm symptoms, start with a 5-HT3 receptor antagonist (ondansetron 8-16 mg IV or 16-24 mg PO daily) or a dopamine antagonist (metoclopramide 10-20 mg PO/IV every 4-6 hours), combined with IV fluid replacement and small frequent meals. 1
Context-Specific Treatment Algorithms
Chemotherapy-Induced Nausea (High Emetogenic Risk)
The evidence here is strongest and most algorithmic:
Day 1 Prevention (Category 1 recommendations):
- Triple therapy: NK1 receptor antagonist (aprepitant/fosaprepitant/rolapitant) + 5-HT3 antagonist (ondansetron/granisetron/palonosetron) + dexamethasone 2, 3
- Alternative: Olanzapine 5-10 mg + palonosetron + dexamethasone 3
- Four-drug option: Add olanzapine to the triple therapy above 2
Days 2-4: Continue modified doses of the above regimen 3
Breakthrough Nausea (Despite Prophylaxis)
Follow this sequential approach 3:
- First-line: Add olanzapine 5-10 mg PO daily if not already given (Category 1) 3
- If olanzapine already used or failed: Add one agent from a different class:
- Lorazepam 0.5-2 mg PO/SL/IV every 6 hours
- Haloperidol 0.5-2 mg PO/IV every 4-6 hours
- Prochlorperazine 10 mg PO/IV every 6 hours or 25 mg PR every 12 hours
- Dronabinol 5-10 mg PO every 4-6 hours or nabilone 1-2 mg PO BID 3
Acute Nausea (General/Non-Chemotherapy)
First-line pharmacologic options 1, 4:
- Serotonin antagonists: Ondansetron 8-16 mg IV or 16-24 mg PO daily
- Dopamine antagonists: Metoclopramide 10-20 mg PO/IV every 4-6 hours
- Phenothiazines: Prochlorperazine 10 mg PO/IV every 6 hours
Critical caveat: Metoclopramide carries risk of extrapyramidal symptoms and tardive dyskinesia; use shortest duration necessary 1
Chronic Nausea (≥4 weeks duration)
Diagnostic approach first 5:
- Rule out structural causes (endoscopy/imaging)
- Exclude metabolic/toxic causes (labs, medication review)
- Consider gastric motility disorders and gut-brain interaction disorders
Treatment hierarchy 5:
- Address underlying cause when identified
- If no cause found: Start with 5-HT3 antagonist or dopamine antagonist
- Target suspected neurotransmitter pathways based on clinical presentation 1
Non-Pharmacologic Measures
Evidence-Based Adjunctive Interventions
For postoperative nausea:
- Preoperative carbohydrate loading ranked highest for reducing PONV incidence (35% probability of being best) 6
- Acupuncture most effective for reducing rescue antiemetic usage (59% probability) 6
- Ginger most effective for reducing severity scores (29% probability) 6
Important limitation: These interventions showed benefit in adults but not in children 7. The evidence quality is low to very low, primarily due to study design limitations 6.
For chemotherapy-induced nausea:
- Evidence remains insufficient to recommend ginger, acupuncture/acupressure, or other complementary therapies 2
- Behavioral therapy with systematic desensitization may be offered for anticipatory nausea 2, 8
Universal Non-Pharmacologic Measures 1
- Fluid and electrolyte replacement (IV if severe dehydration)
- Small, frequent meals rather than large meals
- Avoid trigger foods (identify through patient history)
- Nasogastric decompression if gastric distention or aspiration risk 9
Critical Clinical Pitfalls
Don't delay treatment in acute settings: Vomiting causes dehydration, hypovolemia, and electrolyte imbalances requiring prompt intervention 9
Re-evaluate if breakthrough occurs: Before adding medications, reassess disease status, concurrent illnesses, medications, and verify optimal prophylaxis for emetic risk 2
Medication duration: Use antiemetics for the shortest time necessary to control symptoms due to side effect profiles 1
Medical marijuana vs. FDA-approved cannabinoids: Evidence is insufficient to recommend marijuana over dronabinol or nabilone 2
Multiday chemotherapy: Match antiemetic regimen to the emetic risk of agents given each day plus 2 days post-completion 2